mdl 11939 has been researched along with Serotonin Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Byun, JK; Chung, YH; Jeong, JH; Kim, HC; Ko, SK; Lee, Y; Nabeshima, T; Nah, SY; Nguyen, BT; Sharma, N; Shin, EJ | 1 |
Fox, MA; Gallagher, PS; Jensen, CL; Murphy, DL | 1 |
2 other study(ies) available for mdl 11939 and Serotonin Syndrome
Article | Year |
---|---|
Ginsenoside Re Protects against Serotonergic Behaviors Evoked by 2,5-Dimethoxy-4-iodo-amphetamine in Mice via Inhibition of PKCĪ“-Mediated Mitochondrial Dysfunction.
Topics: Acetophenones; Amphetamines; Animals; Behavior, Animal; Benzopyrans; Ginsenosides; Hypothalamus; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Oxidative Stress; Piperidines; Protein Kinase C-delta; Protein Kinase Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Serotonin Syndrome | 2021 |
Receptor mediation of exaggerated responses to serotonin-enhancing drugs in serotonin transporter (SERT)-deficient mice.
Topics: 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Female; Mice; Mice, Inbred C57BL; Mice, Knockout; Monoamine Oxidase Inhibitors; Piperazines; Piperidines; Polymorphism, Genetic; Pyridines; Receptors, Serotonin; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Serotonin Syndrome; Tranylcypromine | 2007 |